Ahmed A, Ankireddypalli A, Harindhanavudhi T, Moran A, Moheet A
J Clin Transl Endocrinol. 2025; 38:100375.
PMID: 39764279
PMC: 11702000.
DOI: 10.1016/j.jcte.2024.100375.
Schluter D, Keogh R, Daniel R, Agbla S, Taylor-Robinson D
Epidemiology. 2025; 36(2):275-285.
PMID: 39760864
PMC: 11774196.
DOI: 10.1097/EDE.0000000000001826.
Zaveri S, Stecenko A, Hunt W, Goss A, Sharma P, Hartman T
BMJ Open. 2024; 14(12):e092503.
PMID: 39725418
PMC: 11683900.
DOI: 10.1136/bmjopen-2024-092503.
Rose N, Bailey J, Anderson J, Chalamalla A, Ryan K, Acosta E
Pharmacotherapy. 2024; 44(12):920-926.
PMID: 39716404
PMC: 11834086.
DOI: 10.1002/phar.4630.
Gillespie M, Jayaram S, Eisner M, Sliemers S, Pasley K, McCoy K
Pediatr Pulmonol. 2024; 60(1):e27364.
PMID: 39469979
PMC: 11740653.
DOI: 10.1002/ppul.27364.
Impact of Elexacaftor-Tezacaftor-Ivacaftor Therapy on Body Composition, Dietary Intake, Biomarkers, and Quality of Life in People with Cystic Fibrosis: A Prospective Observational Study.
Hevilla F, Porras N, Giron M, Garcia-Olivares M, Padial M, Sanchez-Torralvo F
Nutrients. 2024; 16(19.
PMID: 39408260
PMC: 11478662.
DOI: 10.3390/nu16193293.
Is Obesity a Problem in New Cystic Fibrosis Treatments?.
Solis-Garcia M, Garcia-Clemente M, Madrid-Carbajal C, Pelaez A, Punter R, Bachiller J
Nutrients. 2024; 16(18).
PMID: 39339703
PMC: 11435113.
DOI: 10.3390/nu16183103.
The impact of elexacaftor/tezacaftor/ivacaftor on cystic fibrosis health-related quality of life and decision-making about daily treatment regimens: a mixed methods exploratory study.
Basile M, Polo J, Henthorne K, DeCelie-Germana J, Galvin S, Wang J
Ther Adv Chronic Dis. 2024; 15:20406223241264477.
PMID: 39091508
PMC: 11292704.
DOI: 10.1177/20406223241264477.
"I eat chocolate milk for dinner because we just have nothing in our fridge": The invisible burden and dire consequences of food insecurity for people with cystic fibrosis in the United States.
Niranjan S, Brown G, Bailey J, Geurs R, Robinson K, Schechter M
Pediatr Pulmonol. 2024; 59(12):3228-3239.
PMID: 39041893
PMC: 11601017.
DOI: 10.1002/ppul.27179.
Nutritional Trends in Cystic Fibrosis: Insights from the Italian Cystic Fibrosis Patient Registry.
Salvatore D, Padoan R, Amato A, Salvatore M, Campagna G, The Italian Cf Registry Working Group
J Clin Med. 2024; 13(13).
PMID: 38999218
PMC: 11242145.
DOI: 10.3390/jcm13133652.
Pancreatic Diseases: Genetics and Modeling Using Human Pluripotent Stem Cells.
Lee Y, Lee K
Int J Stem Cells. 2024; 17(3):253-269.
PMID: 38664226
PMC: 11361847.
DOI: 10.15283/ijsc24036.
Elexacaftor/tezacaftor/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis.
Westholter D, Haubold J, Welsner M, Salhofer L, Wienker J, Sutharsan S
Sci Rep. 2024; 14(1):9465.
PMID: 38658613
PMC: 11043331.
DOI: 10.1038/s41598-024-59622-2.
Parental perceptions of body weight and appetite in infants and toddlers with cystic fibrosis.
Duck S, Jansen E, Papantoni A, Sheltry A, Koinis-Mitchell D, DSa V
Appetite. 2024; 198:107357.
PMID: 38621592
PMC: 11134312.
DOI: 10.1016/j.appet.2024.107357.
Predicting weight gain in patients with cystic fibrosis on triple combination modulator.
Stewart K, Szczesniak R, Liou T
Pediatr Pulmonol. 2024; 59(6):1724-1730.
PMID: 38607242
PMC: 11223749.
DOI: 10.1002/ppul.26982.
Calcium, Phosphorus, and Vitamin D Levels in a Series of Cystic Fibrosis Patients: A Cross-Sectional Study.
Escobedo-Monge M, Marcos-Temprano M, Parodi-Roman J, Escobedo-Monge M, Alonso-Vicente C, Torres-Hinojal M
Int J Mol Sci. 2024; 25(3).
PMID: 38339178
PMC: 10856093.
DOI: 10.3390/ijms25031900.
Gastroenterology services for patients with Cystic Fibrosis across Australia and New Zealand: a multi-stakeholder assessment of patients' and professionals' perspectives.
Katz T, Wakefield C, Signorelli C, Day A, Vernon-Roberts A, Ooi C
Front Pediatr. 2024; 11:1322941.
PMID: 38161436
PMC: 10755025.
DOI: 10.3389/fped.2023.1322941.
Factors guiding gastrostomy tube decision-making for caregivers of children with cystic fibrosis: a scoping review protocol.
Zientek E, Rane S, Godfrey C, Sisson A, Dickinson K
BMJ Open. 2023; 13(12):e076539.
PMID: 38149423
PMC: 10711882.
DOI: 10.1136/bmjopen-2023-076539.
The relationship between the intestinal microbiome and body mass index in children with cystic fibrosis.
Bernard R, Shilts M, Strickland B, Boone H, Payne D, Brown R
J Cyst Fibros. 2023; 23(2):242-251.
PMID: 37953184
PMC: 11480998.
DOI: 10.1016/j.jcf.2023.11.002.
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.
Sellers Z, Assis D, Paranjape S, Sathe M, Bodewes F, Bowen M
Hepatology. 2023; 79(5):1220-1238.
PMID: 37934656
PMC: 11020118.
DOI: 10.1097/HEP.0000000000000646.
The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions.
Cheung T, Lee Y, Tang R, She W, Cheng K, Cheung C
Hepatobiliary Surg Nutr. 2023; 12(5):715-735.
PMID: 37886207
PMC: 10598309.
DOI: 10.21037/hbsn-22-471.